15 July 2020 : Clinical Research
Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome
Weiwen Liu1ABC*, Huihong Xu2DE, Xihui Ying1EFG, Dengke Zhang1CD, Linqiang Lai1BC, Linyou Wang3EF, Jianfei Tu1CFG, Jiansong Ji1BDGDOI: 10.12659/MSM.923263
Med Sci Monit 2020; 26:e923263
Figure 8 Patients with ≤40 U/L AST had longer 1-, 2-, 3-, 5-, and 6-year survival rates compared with those with AST >40 U/L (87.3% vs. 67.1%, 71.5% vs. 46.5%, 49.4% vs. 26.5%, 23.0% vs. 11.8%, and 15.4% vs. 0%.